Program Information

2015 Schedule 

Designed to blend the latest advancements in science with practical clinical approaches to patient management, PCNA’s Annual Symposium features keynote addresses, lectures and workshops presented by world-renowned authorities in cardiovascular risk reduction and disease management.

Returning this year: Wednesday afternoon Pharmacology Preconference will cover three important disease management topics. Earn 7 hours of pharmacology credit (Pre-course work and post-course evaluation required).  


Important Information regarding Pharmacology Preconference Slides:

To download the slides for the Pharmacology Preconference please click on the title of the sessions below. 

Antihyperglycemic Agents in the Treatment of Patients with Type 2 Diabetes
Antihyperglycemic Agents_DIGITAL NOTES VERSION
Cindy Lamendola, MSN, ANP-BC, FAHA, FPCNA
CVD Risk Reduction with Lipid-Lowering Medications: Statins and Beyond
Lipid-Lowering_DIGITAL NOTES VERSION
Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA, FAAN
Pharmacotherapy for the Management of Heart Failure
Management of Heart Failure_DIGITAL NOTES VERSION
Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA

Wednesday, April 8           Pharmacology Preconference

*Pharmacology Preconference may be attended as a stand-alone event   

Registration open 9:00 a.m. to 7:00 p.m.

    

                            
11:00 a.m. - 12:15 p.m.   Lunch Product Theater (non-CE)

Cholesterol Management
hosted by Kowa
     
12:30 p.m. - 12:45 p.m.   Welcome

Course Director, Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA

     
12:45 p.m. - 2:15 p.m.  

Antihyperglycemic Agents in the Treatment of Patients with Type 2 Diabetes 
Cindy Lamendola, MSN, ANP-BC, FAHA, FPCNA

     
2:30 p.m. - 3:45 p.m.  

CVD Risk Reduction with Lipid-Lowering Medications: Statins and Beyond
Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA, FAAN

     
3:45 p.m. - 5:00 p.m.   Pharmacotherapy for the Management of Heart Failure
Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA



5:00 p.m. - 5:30 p.m.   Case Studies with All Faculty Panel

Thursday, April 9       Annual Symposium

Registration open 6:30 a.m. to 7:00 p.m.

Exhibit hours are 12:10 p.m. to 2:10 p.m. and 5:00 p.m.

to 6:30 p.m. 


8:15 a.m.   Breakfast
     
8:30 a.m. - 9:15 a.m.  

Welcome, Awards, Annual Review, President's Address

     
9:15 a.m. - 10:15 a.m.  

Management of the Patient with VTE: A Case-Based Approach
Co-hosted by the Society for Vascular Nursing
Sponsored by Boehringer Ingelheim

Kelly Rudd, PharmD, BCPS, CACP
Melody Heffline, MSN, RN, ACNS-BC, ACNP-BC

     
10:25 a.m. - 11:20 a.m.  

Exercise Really IS Medicine
Robert Sallis, MD

     
11:20 a.m. - 12:10 p.m.
 

Heart Health and Brain Health: Same Formula?
Neelum Aggarwal, MD

     
12:20 p.m. - 2:05 p.m.   Exhibits
     
12:20 p.m. - 1:15 p.m.   Lunch Product Theater (non-CE)
Chronic Angina: The Need for Complete Assessment and Management
Hosted by Gilead Science, Inc.
     
12:15 p.m.  

Leadership Luncheon (Invitation Only)
Barbara Drew, RN, PhD, FAAN, FAHA
Hosted by General Mills, Inc.

     
2:10 p.m. - 3:00 p.m.  

Race and Ethnicity: Impact on Heart Disease
Clyde Yancy, MD, MSc, FACC, FAHA, MACP

     
3:05 p.m. - 4:00 p.m.   Repeated concurrent sessions - Choose One

 

 

  Beyond Scare Tactics: Effective Risk Communication Strategies
Lola A. Coke, PhD, ACNS-BC, RN-BC, FAHA, FPCNA

Exercise is Heart Failure Medicine Too
Nancy Houston Miller, RN, BSN, FAHA, FPCNA

Management of Pregnancy in Women with Heart Disease
Mary Canobbio, MN, RN, FAAN

Moderated Poster Session I
     
4:05 p.m. - 5:00 p.m.   Repeated concurrent sessions - Choose One
     
    Beyond Scare Tactics: Effective Risk Communication Strategies
Lola A. Coke, PhD, ACNS-BC, RN-BC, FAHA, FPCNA

Exercise is Heart Failure Medicine Too
Nancy Houston Miller, RN, BSN, FAHA, FPCNA

Management of Pregnancy in Women with Heart Disease
Mary Canobbio, MN, RN, FAAN

Moderated Poster Session II
     
5:00 p.m. - 6:30 p.m.   Exhibits, Opening Reception, and Poster Presentations

 
6:45 p.m. - 7:45 p.m.   Product Theater Dinner (non-CE)
AFib and Stroke Prevention hosted by Janssen Pharmaceuticals
     

Friday, April 10

Registration open 7:30 a.m. to 7:00 p.m.

Exhibit hours are 9:45 a.m. to 10:45 a.m. and 12:15 p.m. to 2:15 p.m.

8:15 a.m.   Breakfast

     
8:30 a.m. - 8:45 a.m.  

Welcome: Fellow Recognition, Poster Winners Announced

     
8:45 a.m. - 9:45 a.m.   The Post-ACS Patient: Adherence to Critical Therapies in the Shot- and Long-Term
Anna Broz, RN, MSN, CNP, Joseph Aragon, MD, FACC, FSCAI
Hosted by AstraZeneca Pharmaceuticals and Merck & Co, In.
     
9:45 a.m. - 10:45 a.m.  

Break / Exhibits Open

     
10:45 a.m. - 11:15 a.m.  

Winning Abstract Presentations 

     
11:20 a.m. - 12:15 p.m.  

What's a Clinician to do? Implementation of the 2013 Prevention Guidelines
Donald Lloyd-Jones, MD, ScM, FACC, FAHA

     
12:20 p.m. - 2:15 p.m.    Exhibits 
     
12:20 p.m. - 1:30 p.m.   Product Theater Lunch (non-CE)

Advancing Knowledge of Hypertriglyceridemia 
Hosted by AstraZeneca
     
2:15 p.m. - 3:05 p.m.  

Beyond Statins: What Does the Future of Dyslipidemia Treatment Hold?
Karol Watson, MD, PhD

     
3:15 p.m. - 4:10 p.m.   Repeated concurrent sessions - Choose one
     

 

  What Can We Offer the Patient with Resistant Hypertension in 2015?
Joel Handler, MD  

Safe Transition from H2H
Kim Newlin, RN, CNS, NP-C, FPCNA

Surgical Approaches to Obesity: Long Term Impact on CV Risk
John Morton, MD, MPH, FACS, FASMBS

Cardiac Device Update: New Tools and New Indications
Robin Trupp, PhD, ACNP-BC, CHFN, FAHA
     
4:15 p.m. - 5:10 p.m.    Repeated concurrent sessions - Choose one
     
   

What Can We Offer the Patient with Resistant Hypertension in 2015?
Joel Handler, MD
  

Safe Transition from H2H
Kim Newlin, RN, CNS, NP-C, FPCNA

Surgical Approaches to Obesity: Long Term Impact on CV Risk
John Morton, MD, MPH, FACS, FASMBS

Cardiac Device Update: New Tools and New Indications
Robin Trupp, PhD, ACNP-BC, CHFN, FAHA

     

Saturday, April 11

Registration open 7:30 a.m. to 12:30 p.m.

8:00 a.m.   Breakfast
     
8:15 a.m. - 8:25 a.m.  

Welcome

     

8:25 a.m. - 9:25 a.m.

 

A Patient-Centered Approach to Lipid Management in the Complicated Patient
Co-hosted by Aegerion Pharmaceuticals, the FH Foundation. and the Foundation of the National Lipid Association. This program is endorsed by the National Lipid Association.

Mary Ann Champagne, MSN, CNS, FAHA, FPCNA
Joshua W. Knowles, MD, PhD
Scott Radabaugh, The FH Foundation Patient Advocate

 

 

 

9:25 a.m. - 10:10 a.m.

 

Women and Stroke: Guidelines for Prevention
Wende Fedder, RN, MBA, FAHA

 

 

 

10:15 a.m. - 11:00 a.m.

 

Menopausal Hormone Therapy and SERMS: Cardiovascular Risks and Benefits
Cynthia Stuenkel, MD, NCMP

 

 

 

11:00 a.m. - 11:45 a.m.

 

Sex and Gender Influences on CVD Management of Women 
Marcia Stefanick, PhD

 

 

 

11:45 a.m. - 12:30 p.m.

 

Pregnancy Complications are Predictors of Cardiovascular Disease in Women
Ellen Seely, MD

     
12:35 p.m.  

Closing



Provider approved by the California Board of Registered Nursing, Provider No. CEP 16268 for 16 Contact Hours.

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program is accredited for 16 contact hours of continuing education, which includes 3 hours of pharmacology. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.

Slides from 2014 Sessions

Access slides from the 2014 PCNA 20th Annual Symposium.